CoreWeave officer Jonathan Jones sells $1.27M shares

CoreWeave's reported shares outstanding were 458,871,690, providing company-wide context for the officer's individual sale.

Rhea-AI Filing Summary

CoreWeave, Inc. officer Jonathan Jones reported a sale of 15,811 common shares, with an aggregate market value of $1,270,651.67, executed October 12, 2026. The shares were sold automatically under a mandatory, non-discretionary sell-to-cover arrangement adopted by CoreWeave to satisfy tax-withholding obligations from vesting and settlement of equity awards.

Key Figures

Common shares sold: 15,811 shares Aggregate market value: $1,270,651.67 Shares outstanding: 458,871,690 shares

3 metrics

Common shares sold 15,811 shares Executed October 12, 2026

Aggregate market value $1,270,651.67 For the reported common shares

Shares outstanding 458,871,690 shares Company-wide share count listed in the securities information

Key Terms

sell-to-cover arrangement, Restricted Stock, tax withholding obligations

3 terms

sell-to-cover arrangement technical

"mandatory, non-discretionary, sell-to-cover arrangement"

Restricted Stock technical

"Nature of acquisition: Restricted Stock"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

tax withholding obligations financial

"satisfying tax withholding obligations incurred upon the vesting and settlement of equity awards"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CRWV shares did Jonathan Jones sell?

Jonathan Jones reported selling 15,811 common shares on October 12, 2026. The shares had an aggregate market value of $1,270,651.67 and were sold automatically under CoreWeave's mandatory, non-discretionary sell-to-cover arrangement for tax withholding on vesting and settlement of equity awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/13/2026 - 08:35 AM EDT Accepted by SEC EDGAR 10/13/2026 - 08:34 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002092880
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	COREWEAVE, INC.
SEC File Number	001-42563
Address of Issuer	290 W. MT. PLEASANT AVENUE, SUITE 4100 LIVINGSTON NEW JERSEY 07039
Phone	(973) 270-9737
Name of Person for Whose Account the Securities are To Be Sold	JONATHAN JONES
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	15811	1270651.67	458871690	10/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/12/2026	Restricted Stock	Issuer			15811	10/12/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The Shares covered by this Form 144 are being sold automatically pursuant to a mandatory, non-discretionary, sell-to-cover arrangement adopted by the Issuer for the purpose of satisfying tax withholding obligations incurred upon the vesting and settlement of equity awards. Sales that were executed on October 12, 2026 are being reported on this Form 144 filed on October 13, 2026 given the EDGAR system was not accepting filings on October 12, 2026 in observance of the federal holiday.
Date of Notice	10/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jonathan Jones
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)